These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 33618613
21. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma]. Song LN, Cen XN, Ou JP, Liang ZY, Qiu ZX, Wang WS, Xu WL, Li Y, Wang MJ, Dong YJ, Yin Y, Sun YH, Liu W, Wang Q, Wang LH, Wang Y, Ren HY. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):387-91. PubMed ID: 23628038 [Abstract] [Full Text] [Related]
23. Primary gastrointestinal diffuse large B-cell lymphoma: A prospective study from South India. Suresh B, Asati V, Lakshmaiah KC, Babu G, Lokanatha D, Jacob LA, Lokesh KN, Rudresh AH, Rajeev LK, Smitha S, Anand A, Patidar R, Premalata CS. South Asian J Cancer; 2019 Apr; 8(1):57-59. PubMed ID: 30766857 [Abstract] [Full Text] [Related]
24. A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era. Lim RMH, Chan NPX, Khoo LP, Cheng CL, Tan L, Poon EYL, Somasundaram N, Farid M, Tang TPL, Tao M, Lim ST, Chan JY. Sci Rep; 2020 Mar 09; 10(1):4373. PubMed ID: 32152442 [Abstract] [Full Text] [Related]
26. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites. Wang C, Li W, Liu C, He H, Bai O. Blood Cells Mol Dis; 2016 Mar 09; 57():42-9. PubMed ID: 26852654 [Abstract] [Full Text] [Related]
30. Endoscopic and image features in primary gastro-intestinal lymphoma: a 7-year experience. Chiu KW, Changchien CS, Chuah SK, Chen CL. Hepatogastroenterology; 1995 Mar 09; 42(4):367-70. PubMed ID: 8586370 [Abstract] [Full Text] [Related]
31. [Primary gastrointestinal lymphoma: a study of 25 cases]. Batlle M, Ribera JM, Llamazares JF, Vaquero M, las Heras G, Flores A, Piñol M, Millá F, Feliu E. Med Clin (Barc); 1992 Oct 24; 99(13):485-8. PubMed ID: 1434971 [Abstract] [Full Text] [Related]
33. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma]. Yao WK, Wang YP, Peng F, Zheng Y, Zou YB, Gao JN, Liu XL. Zhonghua Bing Li Xue Za Zhi; 2012 Dec 24; 41(12):818-22. PubMed ID: 23324230 [Abstract] [Full Text] [Related]
34. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group. Li X, Liu Z, Cao J, Hong X, Wang J, Chen F, Wang C, Zou S, Li J, Shen Z. Ann Hematol; 2012 Jun 24; 91(6):837-45. PubMed ID: 22160255 [Abstract] [Full Text] [Related]
36. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma. Jaime-Pérez JC, Gamboa-Alonso CM, Vázquez-Mellado de Larracoechea A, Rodríguez-Martínez M, Gutiérrez-Aguirre CH, Marfil-Rivera LJ, Gómez-Almaguer D. Arch Med Res; 2015 Aug 24; 46(6):454-61. PubMed ID: 26235285 [Abstract] [Full Text] [Related]